Clinical Indications, Patient Populations and Care Settings

Why Care Setting Is the First Classification Decision

The ECPR devices market covers nine clinical indications and three patient populations, but care setting is the practical classification a device buyer works through first, because a site's existing infrastructure, not the indication label alone, determines which population and indication it is actually equipped to treat.

This report describes indications, populations and care settings strictly as market segmentation categories. It makes no claim about survival rate, neurological outcome or clinical effectiveness for any indication, population, technique or company, in this section or anywhere else in this report.

Reading this page alongside the buyer intelligence detail described across this market's broader research shows that care setting also correlates closely with which decision-maker leads a purchase, since an academic medical centre's ECMO programme director typically leads an indication-driven equipment decision, while a trauma centre or emergency department more often routes the same decision through its department director working alongside a biomedical engineering head.

Seven care setting categories structure this market: academic medical centres, university hospitals, cardiac specialty centres, trauma centres, emergency departments, intensive care units and military medical facilities, each representing a different combination of existing ECMO infrastructure, on-site perfusion expertise and 24-hour readiness.

This report treats care setting as a market structure question, not a clinical protocol question. It describes which setting types typically maintain ECPR capability and which product and deployment categories they favour, without describing the clinical criteria a treating team applies when deciding whether to initiate ECPR in a given case.

Out-of-Hospital and In-Hospital Cardiac Arrest Indications

Out-of-hospital cardiac arrest is the largest clinical indication category by device deployment volume tracked in this report, reflecting the scale of pre-hospital cardiac arrest events relative to in-hospital events across the covered geographies.

In-hospital cardiac arrest indications are concentrated at academic medical centres and cardiac specialty centres already operating a fixed hospital ECMO programme, where an ECPR-capable team can typically be assembled more quickly than in a pre-hospital setting given the proximity of existing equipment and staff.

The distinction between these two indications shapes portability requirements directly: out-of-hospital cardiac arrest response increasingly depends on ambulance deployable or field deployable systems, while in-hospital cardiac arrest response continues to rely primarily on fixed hospital systems already installed within the facility.

Refractory ventricular fibrillation is tracked as a related indication category within this report's cardiac arrest grouping, and institutions building a dedicated refractory arrest response pathway typically standardise on the same portability tier they have already selected for their broader out-of-hospital or in-hospital cardiac arrest programme, rather than procuring a separate system specifically for this sub-category.

Programme scale also differs meaningfully between these two indications: a high-volume ECMO centre managing both indications typically maintains distinct standing equipment allocations for out-of-hospital and in-hospital response, since the two indications draw on different teams, an emergency department or pre-hospital crew for the former and a cardiac surgery or intensive care team for the latter, even when both indications are ultimately managed within the same institution.

Cardiogenic Shock, Pulmonary Embolism and Post-Cardiotomy Support

Cardiogenic shock represents a growing clinical indication category as cardiac specialty centres expand mechanical circulatory support programmes beyond cardiac arrest response alone, extending ECPR-adjacent equipment use into a broader set of critical care scenarios.

Pulmonary embolism indications are concentrated at trauma centres and intensive care units equipped to manage the rapid haemodynamic deterioration associated with a massive embolic event, typically requiring the same rapid-deployment equipment used for cardiac arrest response.

Post-cardiotomy support is a distinct indication category tied specifically to cardiac surgery programmes, where a patient cannot be weaned from cardiopulmonary bypass following an operation, and is managed almost exclusively within the fixed hospital setting where the surgery itself took place.

These three indication categories, together with the cardiac arrest indications described above, account for the great majority of ECPR device deployment volume tracked in this report, with pulmonary embolism representing the smallest of the three by deployment frequency but a category several trauma centres are building dedicated protocol capability around given the speed at which a massive embolic event can deteriorate.

Cardiogenic shock cases also differ from cardiac arrest response in typical support duration, often requiring an extended period of extracorporeal support measured in days rather than the hours-scale intervention more typical of an acute cardiac arrest deployment, a distinction that shapes which disposable circuit and monitoring configuration a care setting keeps on hand as standing inventory.

Because of this longer support duration, cardiogenic shock and post-cardiotomy support indications together account for a disproportionate share of extended disposable circuit consumption relative to their share of total deployment events, a pattern intensive care units and cardiac specialty centres factor into their annual consumables budgeting alongside pure deployment-count estimates.

Bridge-to-Recovery and Bridge-to-Transplant Indications

Bridge-to-recovery is the fastest-growing clinical indication category tracked in this report, reflecting expanding use of ECPR as a stabilisation step ahead of definitive cardiac intervention, and this growth connects directly to the end users typically responsible for each indication, since bridge-to-recovery cases increasingly involve coordination between an ECMO centre of excellence and a referring community hospital rather than a single institution managing the full pathway.

Bridge-to-transplant indications remain a smaller but steady category, concentrated almost entirely at academic medical centres with an active heart transplant programme, where ECPR equipment is one component of a broader advanced heart failure service line.

Both bridge indications share a common procurement characteristic distinct from cardiac arrest response: because the deployment is typically planned or semi-planned rather than a true emergency, the institutions running these programmes place comparatively more weight on device compatibility with longer-duration support and less weight on the rapid setup speed that dominates out-of-hospital cardiac arrest purchasing decisions.

Adult, Pediatric and Neonatal Patient Populations

Adult patients represent the largest patient population category by device deployment volume, reflecting both the overall incidence of cardiac arrest and cardiogenic shock in the adult population and the broader base of institutions equipped to treat adult patients relative to pediatric or neonatal cases.

Pediatric ECPR programmes are growing at a faster pace than the adult population off a smaller installed base, concentrated at academic medical centres and university hospitals with a dedicated pediatric cardiac or critical care service line.

Neonatal patient population equipment is the most specialised category, requiring dedicated circuit sizing and cannulation approaches distinct from adult and pediatric use, and is available at a comparatively small number of academic medical centres with a neonatal intensive care unit and dedicated ECMO programme.

Institutions serving more than one patient population typically maintain separate, appropriately sized cannulation kit inventory for each population rather than attempting to adapt a single adult-sized kit, a practice that shapes how a multi-population academic medical centre structures its disposable circuit procurement relative to a single-population community hospital.

Staffing implications also scale with patient population breadth: a programme covering all three populations typically maintains a correspondingly broader on-call perfusion and ECMO specialist roster than a single-population programme, since pediatric and neonatal cases require staff with population-specific training that adult-only teams do not routinely maintain.

Academic Medical Centres, Trauma Centres and Military Medical Facilities

Care setting connects directly to portability requirement, and that connection is detailed further in the portability tier suited to each care setting, since academic medical centres typically operate the broadest mix of fixed hospital and mobile in-hospital systems, while emergency departments and trauma centres more often prioritise systems that can be brought online quickly within their own department.

Military medical facilities represent a distinct care setting category with procurement requirements shaped by field deployability and ruggedisation needs beyond what a typical civilian trauma centre requires, reflecting the broader Military and Disaster Response Units end user category this report tracks separately.

Intensive care units function as a secondary care setting across nearly every institution type in this report, since ECPR-supported patients are typically transferred to intensive care for ongoing management regardless of which department initiated the deployment.

University hospitals and cardiac specialty centres together form the second-largest care setting grouping by device count, typically operating a narrower architecture mix than a full academic medical centre but a broader mix than a single-department emergency department or trauma centre programme, reflecting their position between these two ends of the care setting spectrum.

The care setting a patient first reaches also shapes which downstream institution eventually manages their case: a trauma centre or emergency department without on-site advanced cardiac surgery capability typically stabilises a patient on a portable or compact mobile system before transferring them to an academic medical centre or cardiac specialty centre for continued management, a transfer pathway that several shared regional ECPR networks are now formalising into a standing clinical and equipment protocol.